spacer

Funding Opportunities

NIDA participates in NIH’s SBIR and STTR Omnibus Funding Opportunity Announcements, issues targeted RFAs and RFPs. In addition, The Program Descriptions and Research Topics Document explains the priority research areas for the SBIR and STTR programs at each of the 24 participating NIH Institutes and Centers (ICs). List of programatic priorities are also outlined in NIDA's NOT-DA-17-013.

New Target Funding Opportunity Announcements (FOAs):

Current Active Program Announcements (PAs):

The four (4) Omnibus parent program announcements have three (3) due dates: September 5, 2019; January 5, 2020; and April 5, 2020:

  • PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) [PA-19-272
  • PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) [PA-19-270
  • PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) [PA-19-273
  • PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) [PA-19-271

Other Program Announcements:

  • Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) [PA-18-837
  • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) [PAR-18-541]
  • Development of Highly Innovative Tools and Technology for Analysis of Single Cells (R43/R44) [PA-17-147]
  • BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research [PAR-18-501] [PAR-18-515]